
Rory Smith contributed to the mrc-ide/malariasimulation repository by developing and refining drug parameterization and malaria modeling workflows, with a focus on P. falciparum and P. vivax. He standardized drug naming, improved parasite-specific parameter validation, and enhanced epidemiological outputs for vivax, ensuring accurate simulation and reproducible research. Using R and R Markdown, Rory implemented robust testing, documentation, and release management practices, addressing bugs in PMC time-stepping and age subsetting logic. His work emphasized maintainability and traceability, with clear documentation updates and technical writing that clarified parameter sources, ultimately supporting more reliable analyses and smoother deployment for malaria simulation stakeholders.

January 2025 monthly summary for mrc-ide/malariasimulation focusing on delivering vivax-focused outputs, improving parasite-type validation, and enhancing documentation for traceability. The work delivered two main features with targeted bug fixes, delivering clearer vivax reporting, improved error handling, and better maintainability. The period also reinforced business value by enabling more accurate vivax analyses and reproducibility across parameter configurations.
January 2025 monthly summary for mrc-ide/malariasimulation focusing on delivering vivax-focused outputs, improving parasite-type validation, and enhancing documentation for traceability. The work delivered two main features with targeted bug fixes, delivering clearer vivax reporting, improved error handling, and better maintainability. The period also reinforced business value by enabling more accurate vivax analyses and reproducibility across parameter configurations.
December 2024 monthly summary for mrc-ide/malariasimulation focusing on key features delivered, bugs fixed, and overall impact. Emphasizes business value of accurate drug efficacy modeling for P. vivax and robust PMC time-step logic, with clear release-readiness.
December 2024 monthly summary for mrc-ide/malariasimulation focusing on key features delivered, bugs fixed, and overall impact. Emphasizes business value of accurate drug efficacy modeling for P. vivax and robust PMC time-step logic, with clear release-readiness.
November 2024 monthly summary for mrc-ide/malariasimulation. Focused on enhancing P. vivax modeling through parameter integration and documentation, and a targeted cleanup of liver-stage prophylaxis logic to improve accuracy and test reliability. These changes strengthen model fidelity, reproducibility, and documentation for stakeholders.
November 2024 monthly summary for mrc-ide/malariasimulation. Focused on enhancing P. vivax modeling through parameter integration and documentation, and a targeted cleanup of liver-stage prophylaxis logic to improve accuracy and test reliability. These changes strengthen model fidelity, reproducibility, and documentation for stakeholders.
October 2024 monthly summary for the mrc-ide/malariasimulation repository focused on delivering a robust, backward-compatible drug parameter handling workflow for P. falciparum. Implemented drug naming standardization and parasite-specific parameter validation warnings within the drug setup flow, accompanied by tests for liver stage prophylaxis calculations. This work reduces parameter attribution errors, improves modeling reliability, and supports reproducible research workflows.
October 2024 monthly summary for the mrc-ide/malariasimulation repository focused on delivering a robust, backward-compatible drug parameter handling workflow for P. falciparum. Implemented drug naming standardization and parasite-specific parameter validation warnings within the drug setup flow, accompanied by tests for liver stage prophylaxis calculations. This work reduces parameter attribution errors, improves modeling reliability, and supports reproducible research workflows.
Overview of all repositories you've contributed to across your timeline